{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:11:36Z","timestamp":1788883896637,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Magnetic resonance imaging (MRI) offers superior soft-tissue contrast and MRI-only radiotherapy (RT) eliminates uncertainties associated with computed tomography (CT)-to-MRI image registration. An MRI-only RT workflow in patients with hip prostheses remains challenging since delineation, synthetic CT (sCT) generation, and marker identification ideally rely on MR images, which are sensitive to distortions. Metal-artifact reduction sequences (MARS) mitigate metal distortions but often obscure gold markers. The aim of this study is to present a proof-of-concept 3 T MRI-only RT workflow for prostate cancer patients with hip prostheses, using only MARS MAVRIC-SL (GE HealthCare) for delineation, sCT generation and fiducial marker identification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five prostate cancer patients with one or two hip prostheses and intraprostatic fiducial markers underwent CT, standard 3 T MRI and additional MAVRIC-SL MRI. All images were used retrospectively and did not affect patient treatment. Delineation and sCT generation were performed using MAVRIC-SL. Intraprostatic markers were not visible in MAVRIC-SL due to artifact suppression; instead, raw data were reconstructed into spectral-bin images to manually identify the markers. To prevent incoming radiation from passing through the implants and reduce the associated uncertainties in dose calculation and treatment delivery, beam avoidance sectors (AS) were applied. Conventional CT-based avoidance sectors were registered to the sCT and defined as AS1. Prosthesis-induced signal voids in MAVRIC-SL were used to define AS2. Two treatment plans (42.7\u00a0Gy, 7 fractions) were created per patient using AS1 and AS2. Plans were compared using dose-volume histogram (DVH) parameters. AS2-plans were recalculated on registered CTs for DVH-comparison and gamma analyses (2%\/2\u00a0mm and 1%\/1\u00a0mm with 10% dose threshold) were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Delineation, marker identification and sCT generation were successful using MAVRIC-SL. Median dose differences between AS1 and AS2 remained within \u00b1\u20090.1% for PTV, while OAR metrics ranged from \u2212\u20090.4% to +\u20090.7%. AS2-plans recalculated on CT showed dose differences\u2009\u2264\u20090.9% for PTV and \u2264\u20091% for OARs. Median gamma pass rates were 99.1% (2%\/2\u00a0mm) and 96.4% (1%\/1\u00a0mm).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates the feasibility of an MRI-only radiotherapy workflow at 3 T for prostate cancer patients with hip prostheses, enabling delineation, sCT generation, dose calculation and marker identification from a single MAVRIC-SL acquisition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-026-02922-w","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:16:37Z","timestamp":1788786997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification"],"prefix":"10.1186","volume":"21","author":[{"given":"Mizgin","family":"Coskun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Stefan","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha af","family":"Wetterstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Brynolfsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Jamtheim","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalsteinn","family":"Gunnlaugsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Siversson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2922_CR1","unstructured":"Cancerfonden. (n.d.). Statistik prostatacancer \u2013 d\u00f6dlighet & \u00f6verlevnad. Cancerfonden. Retrieved October 2. 2025, from https:\/\/www.cancerfonden.se\/om-cancer\/statistik\/prostatacancer"},{"key":"2922_CR2","unstructured":"Cancerfonden. (n.d.). Str\u00e5lbehandling \u2013 behandling och biverkningar. Retrieved December 11. 2025, from https:\/\/www.cancerfonden.se\/om-cancer\/behandlingar\/stralbehandling"},{"issue":"5","key":"2922_CR3","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ijrobp.2008.03.031","volume":"72","author":"AR Yeung","year":"2008","unstructured":"Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008;72(5):1426\u201333. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.031.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2922_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.rli.0000156312.24604.7c","volume":"40","author":"G Jia","year":"2005","unstructured":"Jia G, Baudendistel KT, von Tengg-Kobligk H, Heverhagen JT, Polzer H, Henry H, McAuliffe MJ, Levine AL, Rosol TJ, Knopp MV. Assessing prostate volume by magnetic resonance imaging: a comparison of different measurement approaches for organ volume analysis. Invest Radiol. 2005;40(4):243\u20138. https:\/\/doi.org\/10.1097\/01.rli.0000156312.24604.7c.","journal-title":"Invest Radiol"},{"issue":"5","key":"2922_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/s0360-3016(03)01446-9","volume":"57","author":"RJ Steenbakkers","year":"2003","unstructured":"Steenbakkers RJ, Deurloo KE, Nowak PJ, Lebesque JV, van Herk M, Rasch CR. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2003;57(5):1269\u201379. https:\/\/doi.org\/10.1016\/s0360-3016(03)01446-9.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1176","key":"2922_CR6","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/bjr\/tqaf159","volume":"98","author":"JJ Wyatt","year":"2025","unstructured":"Wyatt JJ, Hedley S, Richmond N, West S, Brooks-Pearson RL, Wintle T, Pearson RA. Dose differences between patients treated with MR-only, CT-only, or MR-CT fusion radiotherapy for prostate cancer. Br J Radiol. 2025;98(1176):2099\u2013105. https:\/\/doi.org\/10.1093\/bjr\/tqaf159.","journal-title":"Br J Radiol"},{"key":"2922_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1748-717X-4-54","volume":"4","author":"T Nyholm","year":"2009","unstructured":"Nyholm T, Nyberg M, Karlsson MG, Karlsson M. Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments. Radiation Oncol (London England). 2009;4:54. https:\/\/doi.org\/10.1186\/1748-717X-4-54.","journal-title":"Radiation Oncol (London England)"},{"key":"2922_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.radonc.2018.12.029","volume":"133","author":"J Wyatt","year":"2019","unstructured":"Wyatt J, McCallum H. Applying a commercial atlas-based synthetic Computed Tomography algorithm to patients with hip prostheses for prostate Magnetic Resonance-only radiotherapy. Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol. 2019;133:100\u20135. https:\/\/doi.org\/10.1016\/j.radonc.2018.12.029.","journal-title":"Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"3","key":"2922_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.radonc.2017.10.011","volume":"125","author":"L Koivula","year":"2017","unstructured":"Koivula L, Kapanen M, Sepp\u00e4l\u00e4 T, Collan J, Dowling JA, Greer PB, Gustafsson C, Gunnlaugsson A, Olsson LE, Wee L, Korhonen J. Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scanners. Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol. 2017;125(3):411\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2017.10.011.","journal-title":"Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol"},{"key":"2922_CR10","doi-asserted-by":"publisher","unstructured":"Nosrati R, Lam WW, Paudel M, Pejovi\u0107-Mili\u0107 A, Morton G, Stanisz GJ. Feasibility of using a single MRI acquisition for fiducial marker localization and synthetic CT generation towards MRI-only prostate radiation therapy treatment planning. Biomed Phys Eng Expr. 2021;7(4). https:\/\/doi.org\/10.1088\/2057-1976\/ac0501.","DOI":"10.1088\/2057-1976\/ac0501"},{"issue":"11","key":"2922_CR11","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1002\/mp.12516","volume":"44","author":"C Gustafsson","year":"2017","unstructured":"Gustafsson C, Korhonen J, Persson E, Gunnlaugsson A, Nyholm T, Olsson LE. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy. Med Phys. 2017;44(11):5563\u201374. https:\/\/doi.org\/10.1002\/mp.12516.","journal-title":"Med Phys"},{"issue":"3","key":"2922_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ijrobp.2017.06.006","volume":"99","author":"E Persson","year":"2017","unstructured":"Persson E, Gustafsson C, Nordstr\u00f6m F, Sohlin M, Gunnlaugsson A, Petruson K, Rintel\u00e4 N, Hed K, Blomqvist L, Zackrisson B, Nyholm T, Olsson LE, Siversson C, Jonsson J. MR-OPERA: A Multicenter\/Multivendor Validation of Magnetic Resonance Imaging-Only Prostate Treatment Planning Using Synthetic Computed Tomography Images. Int J Radiat Oncol Biol Phys. 2017;99(3):692\u2013700. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.006.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2922_CR13","unstructured":"W-Dahl A, K\u00e4rrholm J, Rogmark C, Johansson O, Ighani Arani P, Mohaddes M, Rolfson O. \u00c5rsrapport 2024. Svenska Ledprotesregistret. 2024. https:\/\/registercentrum.blob.core.windows.net\/slr\/r\/-rsrapport-2024-Svenska-Ledprotesregistret-Ze531aeCZ.pdf."},{"issue":"6","key":"2922_CR14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1118\/1.1565113","volume":"30","author":"C Reft","year":"2003","unstructured":"Reft C, Alecu R, Das IJ, Gerbi BJ, Keall P, Lief E, Mijnheer BJ, Papanikolaou N, Sibata C, Van Dyk J, AAPM Radiation Therapy Committee Task Group 63. Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63. Med Phys. 2003;30(6):1162\u201382. https:\/\/doi.org\/10.1118\/1.1565113.","journal-title":"Med Phys"},{"issue":"6","key":"2922_CR15","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/mrm.26313","volume":"77","author":"X Shi","year":"2017","unstructured":"Shi X, Yoon D, Koch KM, Hargreaves BA. Metallic implant geometry and susceptibility estimation using multispectral B0 field maps. Magn Reson Med. 2017;77(6):2402\u201313. https:\/\/doi.org\/10.1002\/mrm.26313.","journal-title":"Magn Reson Med"},{"issue":"3","key":"2922_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2214\/AJR.11.7364","volume":"197","author":"BA Hargreaves","year":"2011","unstructured":"Hargreaves BA, Worters PW, Pauly KB, Pauly JM, Koch KM, Gold GE. Metal-induced artifacts in MRI. AJR Am J Roentgenol. 2011;197(3):547\u201355. https:\/\/doi.org\/10.2214\/AJR.11.7364.","journal-title":"AJR Am J Roentgenol"},{"issue":"22","key":"2922_CR17","doi-asserted-by":"publisher","first-page":"R323","DOI":"10.1088\/0031-9155\/60\/22\/R323","volume":"60","author":"MA Schmidt","year":"2015","unstructured":"Schmidt MA, Payne GS. Radiotherapy planning using MRI. Phys Med Biol. 2015;60(22):R323\u201361. https:\/\/doi.org\/10.1088\/0031-9155\/60\/22\/R323.","journal-title":"Phys Med Biol"},{"issue":"6","key":"2922_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/acm2.13255","volume":"22","author":"S Puvanasunthararajah","year":"2021","unstructured":"Puvanasunthararajah S, Fontanarosa D, Wille ML, Camps SM. The application of metal artifact reduction methods on computed tomography scans for radiotherapy applications: A literature review. J Appl Clin Med Phys. 2021;22(6):198\u2013223. https:\/\/doi.org\/10.1002\/acm2.13255.","journal-title":"J Appl Clin Med Phys"},{"issue":"6","key":"2922_CR19","doi-asserted-by":"publisher","first-page":"NP41","DOI":"10.1177\/0300891621997549","volume":"107","author":"M Felisi","year":"2021","unstructured":"Felisi M, Monti AF, Lizio D, Nici S, Pellegrini RG, Riga S, Bortolato B, Brambilla MG, Carbonini C, Abujami M, Carsana C, Sibio D, Potente C, Vanzulli A, Palazzi MF, Torresin A. MRI only in a patient with prostate cancer with bilateral metal hip prostheses: case study. Tumori. 2021;107(6):NP41\u20134. https:\/\/doi.org\/10.1177\/0300891621997549.","journal-title":"Tumori"},{"key":"2922_CR20","doi-asserted-by":"publisher","first-page":"100469","DOI":"10.1016\/j.phro.2023.100469","volume":"27","author":"L Koivula","year":"2023","unstructured":"Koivula L, Sepp\u00e4l\u00e4 T, Collan J, Visap\u00e4\u00e4 H, Tenhunen M, Korhonen A. Synthetic computed tomography based dose calculation in prostate cancer patients with hip prostheses for magnetic resonance imaging-only radiotherapy. Phys imaging radiation Oncol. 2023;27:100469. https:\/\/doi.org\/10.1016\/j.phro.2023.100469.","journal-title":"Phys imaging radiation Oncol"},{"issue":"3","key":"2922_CR21","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1055\/s-0039-1687898","volume":"23","author":"I Khodarahmi","year":"2019","unstructured":"Khodarahmi I, Isaac A, Fishman EK, Dalili D, Fritz J. Metal About the Hip and Artifact Reduction Techniques: From Basic Concepts to Advanced Imaging. Semin Musculoskelet Radiol. 2019;23(3):e68\u201381. https:\/\/doi.org\/10.1055\/s-0039-1687898.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"7","key":"2922_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00256-015-2128-2","volume":"44","author":"A Lazik","year":"2015","unstructured":"Lazik A, Landgraeber S, Schulte P, Kraff O, Lauenstein TC, Theysohn JM. Usefulness of metal artifact reduction with WARP technique at 1.5 and 3T MRI in imaging metal-on-metal hip resurfacings. Skeletal Radiol. 2015;44(7):941\u201351. https:\/\/doi.org\/10.1007\/s00256-015-2128-2.","journal-title":"Skeletal Radiol"},{"issue":"4","key":"2922_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0035-1563734","volume":"19","author":"T Ariyanayagam","year":"2015","unstructured":"Ariyanayagam T, Malcolm PN, Toms AP. Advances in Metal Artifact Reduction Techniques for Periprosthetic Soft Tissue Imaging. Semin Musculoskelet Radiol. 2015;19(4):328\u201334. https:\/\/doi.org\/10.1055\/s-0035-1563734.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"1","key":"2922_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/mrm.22523","volume":"65","author":"KM Koch","year":"2011","unstructured":"Koch KM, Brau AC, Chen W, Gold GE, Hargreaves BA, Koff M, McKinnon GC, Potter HG, King KF. Imaging near metal with a MAVRIC-SEMAC hybrid. Magn Reson Med. 2011;65(1):71\u201382. https:\/\/doi.org\/10.1002\/mrm.22523.","journal-title":"Magn Reson Med"},{"key":"2922_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.phro.2018.04.005","volume":"6","author":"J Wyatt","year":"2018","unstructured":"Wyatt J, Hedley S, Johnstone E, Speight R, Kelly C, Henry A, Short S, Murray L, Sebag-Montefiore D, McCallum H. Evaluating the repeatability and set-up sensitivity of a large field of view distortion phantom and software for magnetic resonance-only radiotherapy. Phys imaging radiation Oncol. 2018;6:31\u20138. https:\/\/doi.org\/10.1016\/j.phro.2018.04.005.","journal-title":"Phys imaging radiation Oncol"},{"issue":"8","key":"2922_CR26","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1088\/1361-6560\/aa5fa2","volume":"62","author":"C Gustafsson","year":"2017","unstructured":"Gustafsson C, Nordstr\u00f6m F, Persson E, Brynolfsson J, Olsson LE. Assessment of dosimetric impact of system specific geometric distortion in an MRI only based radiotherapy workflow for prostate. Phys Med Biol. 2017;62(8):2976\u201389. https:\/\/doi.org\/10.1088\/1361-6560\/aa5fa2.","journal-title":"Phys Med Biol"},{"issue":"2","key":"2922_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejmp.2014.12.001","volume":"31","author":"S M\u00e5nsson","year":"2015","unstructured":"M\u00e5nsson S, M\u00fcller GM, Wellman F, Nittka M, Lundin B. Phantom based qualitative and quantitative evaluation of artifacts in MR images of metallic hip prostheses. Physica medica: PM : an Int J devoted Appl Phys Med biology : official J Italian Association Biomedical Phys (AIFB). 2015;31(2):173\u20138. https:\/\/doi.org\/10.1016\/j.ejmp.2014.12.001.","journal-title":"Physica medica: PM : an Int J devoted Appl Phys Med biology : official J Italian Association Biomedical Phys (AIFB)"},{"issue":"4","key":"2922_CR28","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ijrobp.2016.02.059","volume":"95","author":"J Weygand","year":"2016","unstructured":"Weygand J, Fuller CD, Ibbott GS, Mohamed AS, Ding Y, Yang J, Hwang KP, Wang J. Spatial Precision in Magnetic Resonance Imaging-Guided Radiation Therapy: The Role of Geometric Distortion. Int J Radiat Oncol Biol Phys. 2016;95(4):1304\u201316. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.02.059.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2922_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13246-014-0252-2","volume":"37","author":"A Walker","year":"2014","unstructured":"Walker A, Liney G, Metcalfe P, Holloway L. MRI distortion: considerations for MRI based radiotherapy treatment planning. Australasian Phys Eng Sci Med. 2014;37(1):103\u201313. https:\/\/doi.org\/10.1007\/s13246-014-0252-2.","journal-title":"Australasian Phys Eng Sci Med"},{"issue":"4","key":"2922_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5114\/wo.2021.112518","volume":"25","author":"M Posiewnik","year":"2021","unstructured":"Posiewnik M, Piotrowski T. Validation of the dosimetric and geometric accuracy of MR-only treatment planning solution for prostate cancer radiotherapy. Contemp Oncol (Poznan Poland). 2021;25(4):249\u201353. https:\/\/doi.org\/10.5114\/wo.2021.112518.","journal-title":"Contemp Oncol (Poznan Poland)"},{"issue":"2","key":"2922_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.zemedi.2023.05.001","volume":"34","author":"M Nachbar","year":"2024","unstructured":"Nachbar M, Lo Russo M, Gani C, Boeke S, Wegener D, Paulsen F, Zips D, Roque T, Paragios N, Thorwarth D. Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy. Z Med Phys. 2024;34(2):197\u2013207. https:\/\/doi.org\/10.1016\/j.zemedi.2023.05.001.","journal-title":"Z Med Phys"},{"issue":"1","key":"2922_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13244-023-01502-w","volume":"14","author":"J Megli\u010d","year":"2023","unstructured":"Megli\u010d J, Sunoqrot MRS, Bathen TF, Elschot M. Label-set impact on deep learning-based prostate segmentation on MRI. Insights into imaging. 2023;14(1):157. https:\/\/doi.org\/10.1186\/s13244-023-01502-w.","journal-title":"Insights into imaging"},{"issue":"1","key":"2922_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13014-020-01513-7","volume":"15","author":"E Persson","year":"2020","unstructured":"Persson E, Jamtheim Gustafsson C, Ambolt P, Engelholm S, Ceberg S, B\u00e4ck S, Olsson LE, Gunnlaugsson A. MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria. Radiation Oncol (London England). 2020;15(1):77. https:\/\/doi.org\/10.1186\/s13014-020-01513-7.","journal-title":"Radiation Oncol (London England)"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02922-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:03:11Z","timestamp":1788883391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02922-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2922"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02922-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Regional Ethical Review Board (Dnr 2020\u201306380). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. All participants were informed about the study and provided written informed consent to participate.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The co-author CJG is a consultant for GE Healthcare. The co-author PB is a shareholder and board member of Hero Imaging AB, developers of \u2018Hero\u2019. CS is an employee of GE Healthcare\/Spectronic Medical.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"124"}}